News
Smart Portfolio
Markets
undefined
Research Tools
Research Tools
Top Stocks
Top Smart Score Stocks
New
Analysts' Top Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Daily Feeds
Daily Stock Ratings
Daily Insider Transactions
Screeners
Stock Screener
New
Stock Comparison
New
Smart Portfolio
Smart Portfolio
My Portfolio
Overview
My Holdings
My Portfolio Analysis
Crowd Insights
My Community
My Performance
My Public Profile
New
Top Experts
Top Experts
Find & Follow Experts
My Experts
Expert Center
Top Firms
Top Lists
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
New
News
News
Categories
Home
Market News
TipRanks Labs
Ideas & Insights
Stock Analysis
Trending Topics
Coronavirus Stocks
Dividend Stocks
Penny Stocks
FAANG Stocks
Calendars
Calendars
Calendars & Events
Earnings Calendars
Dividend Calendars
Stock Market Holidays
IPO Calendar
Enterprise
Enterprise
Tipranks For Enterprise
Trading Platforms
Hedge Funds
Investor Relations
Investment Advisors
Academic & Research
Plans & Pricing
News
Smart Portfolio
Markets
Notifications
All News
Corona
Category
Sorrento Stock Could Hit $30, Says Analyst
The major U.S. equity-indexes are hovering around all-time highs, and a question that frequently pops up these days,...
Marty Shtrubel
Jan 15, 2021
SRNE
J.P. Morgan Reiterates Neutral Stance on Moderna Following Healthcare Conference
From a company barely known outside industry circles a year ago, Moderna (MRNA) has now become a household...
Marty Shtrubel
Jan 12, 2021
MRNA
Applied DNA Sciences (APDN): Next Stop, $18?
Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Last Friday, Applied DNA...
Marty Shtrubel
Jan 12, 2021
APDN
Inovio: Advaccine Deal Is a Positive but Not a Game Changer, Analyst Says
Inovio Pharmaceuticals’ (INO) 2020 was a tale of two contrasting halves. Shares skyrocketed during the first 6 months...
Marty Shtrubel
Jan 07, 2021
INO
Time to Go Bargain Hunting on Arcturus Stock? Analyst Weighs In
Arcturus Therapeutics (ARCT) investors felt the impact of a thunderous thud on Tuesday, following the share price’s collapse....
Marty Shtrubel
Jan 01, 2021
ARCT
Novavax Stock Is up Over 2,900% This Year. How Much Higher Can It Go?
Returns wise, Novavax (NVAX) has undoubtedly been the most successful coronavirus stock of them all, with 2020 gains...
Marty Shtrubel
Dec 29, 2020
NVAX
Don’t Jump on Moderna Stock Bandwagon, Says Analyst
Last week, Moderna’s (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it...
Marty Shtrubel
Dec 24, 2020
MRNA
Street Still Underestimating Moderna’s Potential, Says Top Analyst
Hot on the heels of the FDA granting EUA (emergency use authorization) for Pfizer/BioNTech’s Covid-19 vaccine BNT162b2, last...
Marty Shtrubel
Dec 21, 2020
MRNA
Moderna: Multi-Year Opportunity for mRNA-1273, Says Analyst
Last week, Moderna (MRNA) kicked off its TeenCOVE Study, dosing the first participants in the Phase 2/3 trial...
Marty Shtrubel
Dec 16, 2020
MRNA
This Coronavirus Stock Has Over 80% Upside, Says J.P. Morgan
Covid-19 has been responsible for a complete shift in how society operates. On a lighter note, it has...
Marty Shtrubel
Dec 11, 2020
NVAX
Is Moderna’s Stock Fully Valued at Current Levels? Analyst Weighs In
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results,...
Marty Shtrubel
Dec 11, 2020
MRNA
Can Inovio Survive a Last-Place Finish in the Race to a COVID 19 Vaccine?
2020 has been some journey for Inovio Pharmaceuticals (INO). For this formerly little-known biotech, the narrative has swung...
Marty Shtrubel
Dec 10, 2020
INO
Moderna, Roche Join On Covid-19 Test; Needham Cuts Rating To Hold
Roche has partnered with Moderna Inc. to use its anti-SARS-CoV-2 S antibody test in mRNA-1273 vaccine research trials....
Sharon Wrobel
Dec 09, 2020
MRNA
ROCHE
Pfizer-BioNTech Covid-19 Vaccine Gets FDA Safety Vote; Mizuho Says Buy
Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according...
Sharon Wrobel
Dec 09, 2020
BNTX
PFE
Eli Lilly, UnitedHealth Partner On Covid-19 Study In High-Risk Patients; Shares Rise
Eli Lilly & Co. and insurer UnitedHealth Group have teamed up to conduct a pragmatic study of the...
Sharon Wrobel
Dec 06, 2020
LLY
Moderna Says COVID-19 Vaccine Shows Durable Immunity; Shares Up 10%
Shares of Moderna surged 10% on Thursday after it revealed subjects in the Phase 1 study led by...
Maya Sasson
Dec 04, 2020
MRNA
Eli Lilly Inks $812.5M Covid-19 Antibody Supply Deal With US; Street Sees 18% Upside
Eli Lilly has struck an $812.5 million agreement with the US government to supply an additional 650,000 vials of...
Sharon Wrobel
Dec 03, 2020
LLY
Pfizer-BioNTech Covid-19 Vaccine Wins UK Emergency Use Approval
Pfizer Inc. and its German partner BioNTech will start to supply the UK with their mRNA vaccine from...
Sharon Wrobel
Dec 02, 2020
BNTX
PFE
Pfizer-BioNTech File For European Covid-19 Vaccine Authorization
Pfizer Inc. and its German partner BioNTech have filed a formal application to the European Medicines Agency (EMA)...
Sharon Wrobel
Dec 01, 2020
BNTX
PFE
Novavax Sinks 9% As US Covid-19 Vaccine Trial Start Delayed Again
Shares of Novavax sank more than 9% in Monday’s pre-market session as the drugmaker further delayed the start...
Sharon Wrobel
Nov 30, 2020
NVAX
Moderna To File For Covid-19 Vaccine Emergency Use Today; Shares Pop 13%
Moderna announced that it will file for US and European emergency use of its COVID-19 vaccine candidate on...
Sharon Wrobel
Nov 30, 2020
MRNA
Moderna Inks UK Deal For 2M Covid-19 Vaccine Doses; Street Sees 15% Downside
Moderna has sealed a deal with the UK government for the supply of another 2 million doses of...
Sharon Wrobel
Nov 30, 2020
MRNA
Moderna Inks EU Supply Deal For 160M Covid-19 Vaccine Doses
Moderna has inked a deal to supply European Union countries with up to 160 million doses of its...
Sharon Wrobel
Nov 25, 2020
MRNA
Merck Snaps Up OncoImmune In $425M Deal To Boost Covid-19 Pipeline
Merck & Co has entered into a definitive agreement to snap up all of the outstanding shares of...
Sharon Wrobel
Nov 23, 2020
MRK
AstraZeneca-Oxford Covid-19 Vaccine Shows 70% Average Efficacy
AstraZeneca said that its coronavirus vaccine candidate, which it is developing together with Oxford University, has shown an...
Sharon Wrobel
Nov 23, 2020
AZN
Regeneron’s Covid-19 Antibody Cocktail Wins FDA Emergency Use Nod
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency...
Sharon Wrobel
Nov 22, 2020
REGN
FDA To Review Pfizer-BioNTech Covid-19 Vaccine On Dec. 10
The US Food and Drug Administration (FDA) will review Pfizer Inc. and BioNTech’s request for emergency use authoriziation...
Sharon Wrobel
Nov 22, 2020
BNTX
PFE
Pfizer Expected to File FDA EUA Application for COVID-19 Vaccine Today
Pfizer plans to submit an application to the FDA for the emergency use of its COVID-19 vaccine today,...
Maya Sasson
Nov 20, 2020
PFE
Mesoblast Teams Up With Novartis to Develop COVID-19/ARDS Stem Cell Therapy; Shares Up 17%
Shares of Mesoblast gained 17% after it announced an exclusive worldwide license and collaboration agreement with Novartis for...
Maya Sasson
Nov 20, 2020
MESO
Eli Lilly Arthritis Drug Gets Emergency Green-Light As COVID-19 Treatment
Eli Lilly and Incyte announced on Thursday that the FDA had granted Emergency Use Authorization (EUA) for the...
Maya Sasson
Nov 20, 2020
LLY
AstraZeneca COVID-19 Vaccine Shows Immune Response In Elderly
AstraZeneca’s coronavirus vaccine candidate, which it is developing together with Oxford University, induced a strong immune response in...
Sharon Wrobel
Nov 19, 2020
AZN
Pfizer-BioNTech Covid-19 Vaccine Shows 95% Efficacy; Shares Climb
Pfizer Inc. and its German partner BioNTech are planning to apply for US emergency use authorization (EUA) for...
Sharon Wrobel
Nov 18, 2020
BNTX
PFE
CureVac To Boost Covid-19 Vaccine Production To 300M Doses In 2021
Germany’s CureVac announced that it will set up a European network to boost the manufacturing capacity of its...
Sharon Wrobel
Nov 18, 2020
CVAC
J&J Targets Data For Covid-19 Vaccine US Authorization By February – Report
Johnson & Johnson expects to have all the data needed to seek U.S. authorization for its experimental COVID-19...
Sharon Wrobel
Nov 18, 2020
JNJ
Pfizer Kicks Off Covid-19 Vaccine Pilot Delivery Program In US – Report
Pfizer Inc has kicked off a pilot delivery program for its COVID-19 vaccine candidate in four US states,...
Sharon Wrobel
Nov 17, 2020
BNTX
PFE
BioNTech, Fosun Pharma Get Green Light To Start Covid-19 Vaccine Trial In China
BioNTech and Shanghai partner Fosun Pharma have been granted regulatory approval to commence the clinical trial for their...
Sharon Wrobel
Nov 17, 2020
BNTX
PFE
Inovio Gets FDA Go-Ahead To Initiate Covid-19 Vaccine Trial; Shares Rise 11%
Shares of Inovio Pharmaceuticals jumped 11% after the US Food & Drug Administration (FDA) cleared the way for...
Sharon Wrobel
Nov 16, 2020
INO
Moderna Says Covid-19 Vaccine Candidate 94.5% Effective; Shares Pop 15%
Shares of Moderna spiked 15% in Monday’s pre-market session as the company disclosed that its vaccine candidate, mRNA-1273,...
Sharon Wrobel
Nov 16, 2020
MRNA
J&J Kicks Off Two-Dose Phase 3 Covid-19 Trial In UK; Street Bullish
Johnson & Johnson said that it has kicked off a Phase 3 clinical trial in the UK to...
Sharon Wrobel
Nov 16, 2020
JNJ
Qiagen Kicks Off Sale Of Rapid Covid-19 Test In US; Shares Gain
Shares of Qiagen rose as much as 4% in Wednesday’s extended market session after the medical diagnostics company...
Sharon Wrobel
Nov 12, 2020
QGEN
Moderna On Cusp Of Covid-19 Vaccine Data Release; Shares Pop 8%
Moderna said it has collated sufficient data for the first interim analysis of the Phase 3 study of...
Sharon Wrobel
Nov 12, 2020
MRNA
Pfizer-BioNTech Win EU Covid-19 Vaccine Supply Deal
Pfizer (PFE) and BioNTech SE have won a contract to supply European Union (EU) Member States with 300 million...
Sharon Wrobel
Nov 11, 2020
BNTX
PFE
Eli Lilly’s Covid-19 Antibody Treatment Gets FDA Emergency Use Nod
Shares of Eli Lilly & Co. rose as much as 5% in Tuesday’s pre-market session after the US...
Sharon Wrobel
Nov 10, 2020
LLY
Humanigen Spikes 13% On Positive Covid-19 Data For Lenzilumab
Humanigen (HGEN) has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with COVID-19. Shares are now...
Harriet Lefton
Nov 06, 2020
HGEN
AstraZeneca Expects Covid-19 Trial Data By Year-End, Backs 2020 Guidance
AstraZeneca will present late-stage trial data for its Covid-19 vaccine candidate later this year as the UK drugmaker...
Sharon Wrobel
Nov 05, 2020
AZN
Hologic Quarterly Profit Triples On Covid-19 Test Sales; Shares Rise
Hologic saw its quarterly earnings more than triple bolstered by strong demand for its COVID-19 tests, sending shares...
Sharon Wrobel
Nov 05, 2020
HOLX
Novavax, Australia Ink Deal For 40M Covid Vaccine Doses; Shares Rise
Novavax (NVAX) has signed a non-binding heads of terms document with the Australian Government to supply 40 million...
Harriet Lefton
Nov 04, 2020
NVAX
Humanigen Inks First Asia Licensing Deal For Its Covid-19 Treatment
Humanigen (HGEN) has announced the execution of its first licensing transaction in the Asia-Pacific Region with Telcon RF Pharmaceutical, Inc....
Harriet Lefton
Nov 03, 2020
HGEN
TFF Teams Up With Augmenta For Covid-19 Antibody Therapies; Shares Pop 7%
Shares in TFF Pharmaceuticals closed 6.5% higher on Monday as the clinical-stage biopharma company announced that it has...
Sharon Wrobel
Nov 03, 2020
TFFP
J&J Strikes Covid-19 Vaccine Manufacturing Deal With Aspen
Johnson & Johnson has struck a preliminary agreement with Aspen Pharmacare Holdings to manufacture its Covid-19 vaccine candidate...
Sharon Wrobel
Nov 02, 2020
JNJ
SHOW MORE
You need to enable JavaScript to run this app.